Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-22-127883

10% owner bought 2,403,049 shares at an average $5.44 ($13,073,874)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2022-12-14 Purchase +824,600 $5.46 $4,501,574 7,824,600 I: show line 1 in the form
RA CAPITAL MANAGEMENT, L.P. 10% owner 2022-12-15 Purchase +237,029 $5.50 $1,302,474 8,061,629 I: show line 2 in the form
RA CAPITAL MANAGEMENT, L.P. 10% owner 2022-12-16 Purchase +1,341,420 $5.42 $7,269,826 9,403,049 I: show line 3 in the form
Open-market purchases · 2,403,049 sh · avg $5.44 · $13,073,874
Loading xslF345X03/tm2232930-1_4.xml…